Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from CSPC Pharmaceutical Group ( (HK:1093) ) is now available.
CSPC Pharmaceutical Group Limited has announced the composition of its Board of Directors, detailing the roles and functions of each member. This announcement is crucial for stakeholders as it outlines the leadership structure and governance, which can impact the company’s strategic direction and operational effectiveness.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a Hong Kong-based company operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of a wide range of pharmaceutical products.
Average Trading Volume: 165,026,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$88.46B
For an in-depth examination of 1093 stock, go to TipRanks’ Overview page.